vs
Axogen, Inc.（AXGN）与Electromed, Inc.（ELMD）财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是Electromed, Inc.的3.2倍（$59.9M vs $18.9M）。Electromed, Inc.净利率更高（14.6% vs -22.0%，领先36.6%）。Axogen, Inc.同比增速更快（21.3% vs 16.3%）。Electromed, Inc.自由现金流更多（$2.4M vs $1.8M）。过去两年Axogen, Inc.的营收复合增速更高（20.3% vs 16.7%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
Electromed, Inc.是一家专注于呼吸护理设备研发、生产与销售的医疗设备企业，核心产品为高频胸壁振荡排痰系统，主要服务美国市场的家庭护理及临床医疗机构，为囊性纤维化、慢阻肺等呼吸系统疾病患者提供气道清理解决方案。
AXGN vs ELMD — 直观对比
营收规模更大
AXGN
是对方的3.2倍
$18.9M
营收增速更快
AXGN
高出5.0%
16.3%
净利率更高
ELMD
高出36.6%
-22.0%
自由现金流更多
ELMD
多$601.0K
$1.8M
两年增速更快
AXGN
近两年复合增速
16.7%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $59.9M | $18.9M |
| 净利润 | $-13.2M | $2.8M |
| 毛利率 | 74.1% | 78.4% |
| 营业利润率 | -16.3% | 19.2% |
| 净利率 | -22.0% | 14.6% |
| 营收同比 | 21.3% | 16.3% |
| 净利润同比 | -3023.6% | 40.3% |
| 每股收益（稀释后） | $-0.28 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNELMD
| Q4 25 | $59.9M | $18.9M | ||
| Q3 25 | $60.1M | $16.9M | ||
| Q2 25 | $56.7M | $17.4M | ||
| Q1 25 | $48.6M | $15.7M | ||
| Q4 24 | $49.4M | $16.3M | ||
| Q3 24 | $48.6M | $14.7M | ||
| Q2 24 | $47.9M | $14.8M | ||
| Q1 24 | $41.4M | $13.9M |
净利润AXGNELMD
| Q4 25 | $-13.2M | $2.8M | ||
| Q3 25 | $708.0K | $2.1M | ||
| Q2 25 | $579.0K | $2.2M | ||
| Q1 25 | $-3.8M | $1.9M | ||
| Q4 24 | $450.0K | $2.0M | ||
| Q3 24 | $-1.9M | $1.5M | ||
| Q2 24 | $-1.9M | $1.8M | ||
| Q1 24 | $-6.6M | $1.5M |
毛利率AXGNELMD
| Q4 25 | 74.1% | 78.4% | ||
| Q3 25 | 76.6% | 78.1% | ||
| Q2 25 | 74.2% | 78.3% | ||
| Q1 25 | 71.9% | 78.0% | ||
| Q4 24 | 76.1% | 77.7% | ||
| Q3 24 | 74.9% | 78.3% | ||
| Q2 24 | 73.8% | 76.2% | ||
| Q1 24 | 78.8% | 74.8% |
营业利润率AXGNELMD
| Q4 25 | -16.3% | 19.2% | ||
| Q3 25 | 3.2% | 15.8% | ||
| Q2 25 | 3.0% | 17.5% | ||
| Q1 25 | -3.4% | 13.6% | ||
| Q4 24 | 4.1% | 15.6% | ||
| Q3 24 | -0.6% | 13.2% | ||
| Q2 24 | -0.9% | 15.7% | ||
| Q1 24 | -11.0% | 13.3% |
净利率AXGNELMD
| Q4 25 | -22.0% | 14.6% | ||
| Q3 25 | 1.2% | 12.6% | ||
| Q2 25 | 1.0% | 12.7% | ||
| Q1 25 | -7.9% | 12.1% | ||
| Q4 24 | 0.9% | 12.1% | ||
| Q3 24 | -3.8% | 10.0% | ||
| Q2 24 | -4.0% | 12.3% | ||
| Q1 24 | -16.0% | 10.8% |
每股收益（稀释后）AXGNELMD
| Q4 25 | $-0.28 | $0.32 | ||
| Q3 25 | $0.01 | $0.25 | ||
| Q2 25 | $0.01 | $0.26 | ||
| Q1 25 | $-0.08 | $0.21 | ||
| Q4 24 | $-0.00 | $0.22 | ||
| Q3 24 | $-0.04 | $0.16 | ||
| Q2 24 | $-0.04 | $0.20 | ||
| Q1 24 | $-0.15 | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.5M | $13.8M |
| 总债务越低越好 | $48.4M | — |
| 股东权益账面价值 | $128.8M | $45.4M |
| 总资产 | $221.7M | $54.9M |
| 负债/权益比越低杠杆越低 | 0.38× | — |
8季度趋势，按日历期对齐
现金及短期投资AXGNELMD
| Q4 25 | $41.5M | $13.8M | ||
| Q3 25 | $35.8M | $14.1M | ||
| Q2 25 | $29.9M | $15.3M | ||
| Q1 25 | $22.1M | $15.2M | ||
| Q4 24 | $33.5M | $16.2M | ||
| Q3 24 | $24.5M | $13.9M | ||
| Q2 24 | $21.1M | $16.1M | ||
| Q1 24 | $17.6M | $11.7M |
总债务AXGNELMD
| Q4 25 | $48.4M | — | ||
| Q3 25 | $48.2M | — | ||
| Q2 25 | $47.9M | — | ||
| Q1 25 | $47.7M | — | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $47.3M | — | ||
| Q2 24 | $47.0M | — | ||
| Q1 24 | $46.8M | — |
股东权益AXGNELMD
| Q4 25 | $128.8M | $45.4M | ||
| Q3 25 | $120.8M | $44.7M | ||
| Q2 25 | $112.3M | $43.2M | ||
| Q1 25 | $105.4M | $43.9M | ||
| Q4 24 | $103.9M | $43.6M | ||
| Q3 24 | $99.4M | $41.5M | ||
| Q2 24 | $95.7M | $44.5M | ||
| Q1 24 | $93.2M | $42.5M |
总资产AXGNELMD
| Q4 25 | $221.7M | $54.9M | ||
| Q3 25 | $216.4M | $53.6M | ||
| Q2 25 | $205.5M | $53.8M | ||
| Q1 25 | $196.2M | $52.5M | ||
| Q4 24 | $203.7M | $52.3M | ||
| Q3 24 | $192.0M | $48.9M | ||
| Q2 24 | $188.9M | $52.2M | ||
| Q1 24 | $186.5M | $48.9M |
负债/权益比AXGNELMD
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $3.0M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | $2.4M |
| 自由现金流率自由现金流/营收 | 3.0% | 12.7% |
| 资本支出强度资本支出/营收 | 2.1% | 3.4% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $-2.9M | $7.9M |
8季度趋势，按日历期对齐
经营现金流AXGNELMD
| Q4 25 | $3.0M | $3.0M | ||
| Q3 25 | $3.2M | $169.0K | ||
| Q2 25 | $7.7M | $3.9M | ||
| Q1 25 | $-13.2M | $2.1M | ||
| Q4 24 | $8.7M | $3.2M | ||
| Q3 24 | $3.9M | $2.3M | ||
| Q2 24 | $4.2M | $4.5M | ||
| Q1 24 | $-12.3M | $1.4M |
自由现金流AXGNELMD
| Q4 25 | $1.8M | $2.4M | ||
| Q3 25 | $1.7M | $-83.0K | ||
| Q2 25 | $7.0M | $3.7M | ||
| Q1 25 | $-13.4M | $1.9M | ||
| Q4 24 | $8.1M | $2.9M | ||
| Q3 24 | $3.3M | $2.3M | ||
| Q2 24 | $3.3M | $4.5M | ||
| Q1 24 | $-13.2M | $1.3M |
自由现金流率AXGNELMD
| Q4 25 | 3.0% | 12.7% | ||
| Q3 25 | 2.8% | -0.5% | ||
| Q2 25 | 12.4% | 21.4% | ||
| Q1 25 | -27.7% | 12.2% | ||
| Q4 24 | 16.3% | 18.0% | ||
| Q3 24 | 6.8% | 15.5% | ||
| Q2 24 | 6.8% | 30.1% | ||
| Q1 24 | -31.9% | 9.1% |
资本支出强度AXGNELMD
| Q4 25 | 2.1% | 3.4% | ||
| Q3 25 | 2.5% | 1.5% | ||
| Q2 25 | 1.3% | 0.8% | ||
| Q1 25 | 0.5% | 1.0% | ||
| Q4 24 | 1.4% | 1.4% | ||
| Q3 24 | 1.2% | 0.3% | ||
| Q2 24 | 1.9% | 0.1% | ||
| Q1 24 | 2.2% | 0.6% |
现金转化率AXGNELMD
| Q4 25 | — | 1.10× | ||
| Q3 25 | 4.55× | 0.08× | ||
| Q2 25 | 13.35× | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | 19.41× | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 0.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
